Indeed, it has been reported that several disease-related mutations in critical target genes, such as DNMT3A or TET2, are detectable in a subset of healthy individuals (CHIP) or those with  ́skewed ́ hematopoiesis without an overt MDS or AML [13-15]. This evidence concerns the gene DNMT3A and acute myeloid leukemia.